Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency

OBJECTIVE: The objective of this study is to evaluate the economic benefits of immunoglobulin replacement therapy achieved subcutaneously (subcutaneous immunoglobulin, SCIG) by the rapid push method compared to intravenous infusion therapy (intravenous immunoglobulin, IVIG) in primary immune deficie...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, A, Lavoie, L, Goetghebeur, M, Schellenberg, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580879/
https://www.ncbi.nlm.nih.gov/pubmed/23167310
http://dx.doi.org/10.1111/j.1365-3148.2012.01201.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580879/
https://www.ncbi.nlm.nih.gov/pubmed/23167310
http://dx.doi.org/10.1111/j.1365-3148.2012.01201.x

Ejemplares similares